Table 4 Number of patients with serious adverse events (SAEs; by system organ class) for SAEs occurring in >1% of any treatment group
Number of patients with SAEsRefused surgery n = 40Surgery n = 248Medical n = 266Not randomised n = 72
n (%)n (%)n (%)n (%)
Injury, poisoning, procedural1 (2.5)15 (6.0)2 (0.8)1 (1.5)
Gastrointestinal disorders012 (4.8)5 (1.9)1 (1.5)
Musculoskeletal/connective tissue02 (0.8)8 (3.0)0
Infections and infestations1 (2.5)3 (1.2)6 (2.3)0
General disorders05 (2.0)4 (1.5)0
Cardiac disorders1 (2.5)4 (1.6)3 (1.1)0
Neoplasms, benign/malignant02 (0.8)6 (2.3)0
Reproductive system including breast01 (0.4)4 (1.5)0
Respiratory, thoracic, mediastinal05 (2.0)1 (0.4)0
Vascular disorders03 (1.2)3 (1.1)0
Hepatobiliary disorders1 (2.5)3 (1.2)00